Main Menu

Our Work

Takeda Pharmaceutical Company Limited v. Zydus Pharmaceuticals (USA) Inc.

In Takeda Pharmaceutical Company Limited v. Zydus Pharmaceuticals (USA) Inc., Eric Gaier was retained on behalf of Takeda in connection with antitrust counterclaims filed by Zydus Pharmaceuticals. Zydus alleged that Takeda filed “sham” patent litigation to delay Zydus’s launch of a generic formulation of Takeda’s Prevacid® SoluTab™ drug. Dr. Gaier testified on behalf of Takeda concerning market definition, market power, competitive effects, and damages in connection with Zydus’s antitrust counterclaims. The District Court granted Takeda’s motion for summary judgment on the antitrust counterclaims.

Jump to Page

We use cookies to optimize the performance of this site and give you the best user experience. By clicking "Accept," you agree to our use of cookies.

Necessary Cookies

Necessary cookies enable core functionality such as security, network management, and accessibility. You may disable these by changing your browser settings, but this may affect how the website functions.

Analytical Cookies

Analytical cookies help us improve our website by collecting and reporting information on its usage. We access and process information from these cookies at an aggregate level.